MR-guided adaptive SBRT for prostate cancer: stability of adaptive planning analyzed by repetitive imaging

被引:0
|
作者
Heitmann, Jana
Heitmann, J. [1 ]
Chamberlain, M. [1 ]
Baumgartl, M. [1 ]
Krayenbuhl, J. [1 ]
Zamburlini, M. [1 ]
Mayinger, M. [1 ]
Wilke, L. [1 ]
Andratschke, N. [1 ]
Tanadini-Lang, S. [1 ]
Guckenberger, M. [1 ]
机构
[1] Univ Hosp Zurich, Radiat Oncol, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1149 / 1150
页数:2
相关论文
共 50 条
  • [41] Editorial: Online Adaptive MR-Guided Radiotherapy
    Kerkmeijer, Linda G. W.
    Valentini, Vincenzo
    Fuller, Clifton D.
    Slotman, Ben J. J.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Daily adaptive MR-guided SBRT for oligometastatic lymph-nodes:feasibility and preliminary experience
    Rigo, M.
    Cuccia, F.
    Figlia, V.
    Giaj-Levra, N.
    Mazzola, R.
    Nicosia, L.
    Ricchetti, F.
    Gurrera, D.
    De Simone, A.
    Naccarato, S.
    Sicignano, G.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1239 - S1240
  • [43] Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer
    de Ridder, Mischa
    Raaijmakers, Cornelis P. J.
    Pameijer, Frank A.
    de Bree, Remco
    Reinders, Floris C. J.
    Doornaert, Patricia A. H.
    Terhaard, Chris H. J.
    Philippens, Marielle E. P.
    CANCERS, 2022, 14 (12)
  • [44] 1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients
    Alongi, Filippo
    Rigo, Michele
    Figlia, Vanessa
    Nicosia, Luca
    Mazzola, Rosario
    Levra, Niccolo Giaj
    Ricchetti, Francesco
    Trapani, Giovanna
    Attina, Giorgio
    Vitale, Claudio
    Pastorello, Edoardo
    De Simone, Antonio
    Gurrera, Davide
    Naccarato, Stefania
    Sicignano, Gianluisa
    Ruggieri, Ruggero
    Cuccia, Francesco
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
  • [45] Clinical experience with MR-guided adaptive SABR for inoperable pancreatic cancer
    Teoh, S.
    Owens, R.
    Bungay, H.
    George, B.
    Drabble, J.
    Lamming, J.
    Mckenzie, J.
    Chauhan, J.
    Dhanda, V.
    Chu, K.
    Sabharwal, A.
    Camilleri, P.
    Good, J.
    Maughan, T.
    Mukherjee, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1082 - S1083
  • [46] Stereotactic MR-Guided Adaptive Radiation Therapy for Inoperable Pancreatic Cancer
    Van Heijst, T.
    Mases, J.
    Viol, S. L. Meyer
    Brand, E.
    Terhaard, C. H. J.
    Doornaert, P. H.
    Philippens, M. E. P.
    Raaijmakers, C. P. J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S381 - S382
  • [47] Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy
    Christiansen, R. L.
    Dysager, L.
    Hansen, C. R.
    Schytte, T.
    Bertelsen, A. S.
    Jensen, H. R.
    Mahmood, F.
    Nyborg, C. J.
    Hansen, S.
    Agergaard, S. N.
    Hansen, O.
    Brink, C.
    Bernchou, U.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1488 - S1489
  • [48] First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer
    Kuenzel, Luise A.
    Nachbar, Marcel
    Hagmueller, Markus
    Gani, Cihan
    Boeke, Simon
    Zips, Daniel
    Thorwarth, Daniela
    RADIOTHERAPY AND ONCOLOGY, 2021, 159 : 197 - 201
  • [49] 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: preliminary report of feasibility and PROMs
    Cuccia, F.
    Mazzola, R.
    Figlia, V.
    Rigo, M.
    Nicosia, L.
    Giaj-Levra, N.
    Ricchetti, F.
    Vitale, C.
    Attina, G.
    Pastorello, E.
    Di Paola, G.
    De Simone, A.
    Gurrera, D.
    Naccarato, S.
    Sicignano, G.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1138 - S1139
  • [50] Vas deferens metastasis from prostate adenocarcinoma treated with daily-adaptive MR-guided SBRT on 1.5T MR-linac
    Vitale, Claudio
    Nicosia, Luca
    Pastorello, Edoardo
    Rigo, Michele
    Doraku, Joniada
    Salgarello, Matteo
    Alongi, Filippo
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (02) : 371 - 374